<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We measured interleukin-6 (IL-6) levels in 70 serum samples obtained from 25 patients with systemic-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:hpo ids='HP_0005681'>juvenile rheumatoid arthritis</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JRA</z:e>), using the hybridoma cell line B9 </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with systemic-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JRA</z:e> had significantly elevated serum IL-6 levels during active disease (mean +/- SD 92.1 +/- 75.1 hybridoma growth factor units/ml; P less than 0.00001 versus healthy age-matched controls), but not during remission </plain></SENT>
<SENT sid="2" pm="."><plain>Serum IL-6 levels correlated with the extent and severity of joint involvement (P less than 0.001) and with platelet counts (P less than 0.05) </plain></SENT>
<SENT sid="3" pm="."><plain>Our data suggest that IL-6 plays a significant role in the pathogenesis of systemic-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JRA</z:e> </plain></SENT>
</text></document>